184 related articles for article (PubMed ID: 32151681)
1. Advances in molecular mechanisms of drugs affecting abnormal glycosylation and metastasis of breast cancer.
Liu H; Ma L; Lin J; Cao B; Qu D; Luo C; Huang W; Han L; Xu H; Wu Z; Xu R; Zhang D
Pharmacol Res; 2020 May; 155():104738. PubMed ID: 32151681
[TBL] [Abstract][Full Text] [Related]
2. Natural inhibitors of PI3K/AKT signaling in breast cancer: emphasis on newly-discovered molecular mechanisms of action.
Safdari Y; Khalili M; Ebrahimzadeh MA; Yazdani Y; Farajnia S
Pharmacol Res; 2015 Mar; 93():1-10. PubMed ID: 25533812
[TBL] [Abstract][Full Text] [Related]
3. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
[TBL] [Abstract][Full Text] [Related]
4. Targeting ETS1 with RNAi-based supramolecular nanoassemblies for multidrug-resistant breast cancer therapy.
Wu M; Liu X; Jin W; Li Y; Li Y; Hu Q; Chu PK; Tang G; Ping Y
J Control Release; 2017 May; 253():110-121. PubMed ID: 28302581
[TBL] [Abstract][Full Text] [Related]
5. The palladacycle, BTC2, exhibits anti-breast cancer and breast cancer stem cell activity.
Kimani S; Chakraborty S; Irene I; de la Mare J; Edkins A; du Toit A; Loos B; Blanckenberg A; Van Niekerk A; Costa-Lotufo LV; ArulJothi KN; Mapolie S; Prince S
Biochem Pharmacol; 2021 Aug; 190():114598. PubMed ID: 33979647
[TBL] [Abstract][Full Text] [Related]
6. Targeting of HBP1/TIMP3 axis as a novel strategy against breast cancer.
Zhou Y; Zhang T; Wang S; Yang R; Jiao Z; Lu K; Li H; Jiang W; Zhang X
Pharmacol Res; 2023 Aug; 194():106846. PubMed ID: 37414199
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol as MDR reversion molecule in breast cancer: An overview.
Alamolhodaei NS; Tsatsakis AM; Ramezani M; Hayes AW; Karimi G
Food Chem Toxicol; 2017 May; 103():223-232. PubMed ID: 28315369
[TBL] [Abstract][Full Text] [Related]
8. Furanodiene, a natural small molecule suppresses metastatic breast cancer cell migration and invasion in vitro.
Zhong Z; Tan W; Chen X; Wang Y
Eur J Pharmacol; 2014 Aug; 737():1-10. PubMed ID: 24824922
[TBL] [Abstract][Full Text] [Related]
9. Activation of ALDH1A1 in MDA-MB-468 breast cancer cells that over-express CYP2J2 protects against paclitaxel-dependent cell death mediated by reactive oxygen species.
Allison SE; Chen Y; Petrovic N; Zhang J; Bourget K; Mackenzie PI; Murray M
Biochem Pharmacol; 2017 Nov; 143():79-89. PubMed ID: 28756208
[TBL] [Abstract][Full Text] [Related]
10. Targeting bromodomain and extraterminal proteins in breast cancer.
Sahni JM; Keri RA
Pharmacol Res; 2018 Mar; 129():156-176. PubMed ID: 29154989
[TBL] [Abstract][Full Text] [Related]
11. Dichotomous role of microtubule associated protein tau as a biomarker of response to and a target for increasing efficacy of taxane treatment in cancers of epithelial origin.
Barbolina MV
Pharmacol Res; 2021 Jun; 168():105585. PubMed ID: 33798735
[TBL] [Abstract][Full Text] [Related]
12. Machine learning model for anti-cancer drug combinations: Analysis, prediction, and validation.
Zhou JB; Tang D; He L; Lin S; Lei JH; Sun H; Xu X; Deng CX
Pharmacol Res; 2023 Aug; 194():106830. PubMed ID: 37343647
[TBL] [Abstract][Full Text] [Related]
13. Should we keep rocking? Portraits from targeting Rho kinases in cancer.
de Sousa GR; Vieira GM; das Chagas PF; Pezuk JA; Brassesco MS
Pharmacol Res; 2020 Oct; 160():105093. PubMed ID: 32726671
[TBL] [Abstract][Full Text] [Related]
14. The endoplasmic reticulum stress/unfolded protein response in gliomagenesis, tumor progression and as a therapeutic target in glioblastoma.
Peñaranda Fajardo NM; Meijer C; Kruyt FA
Biochem Pharmacol; 2016 Oct; 118():1-8. PubMed ID: 27106078
[TBL] [Abstract][Full Text] [Related]
15. Anti-cancer effects of naturally derived compounds targeting histone deacetylase 6-related pathways.
Lernoux M; Schnekenburger M; Dicato M; Diederich M
Pharmacol Res; 2018 Mar; 129():337-356. PubMed ID: 29133216
[TBL] [Abstract][Full Text] [Related]
16. The ErbB/HER family of protein-tyrosine kinases and cancer.
Roskoski R
Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy and safety of Aidi injection plus paclitaxel-based chemotherapy for advanced non-small cell lung cancer: A meta-analysis of 31 randomized controlled trials following the PRISMA guidelines.
Xiao Z; Wang C; Zhou M; Hu S; Jiang Y; Huang X; Li N; Feng J; Tang F; Chen X; Ding J; Chen L; Wang Y; Li X
J Ethnopharmacol; 2019 Jan; 228():110-122. PubMed ID: 30243827
[TBL] [Abstract][Full Text] [Related]
18. Improving the efficacy of hormone therapy in breast cancer: The role of cholesterol metabolism in SERM-mediated autophagy, cell differentiation and death.
Leignadier J; Dalenc F; Poirot M; Silvente-Poirot S
Biochem Pharmacol; 2017 Nov; 144():18-28. PubMed ID: 28642035
[TBL] [Abstract][Full Text] [Related]
19. Autophagy as a molecular target for cancer treatment.
Kocaturk NM; Akkoc Y; Kig C; Bayraktar O; Gozuacik D; Kutlu O
Eur J Pharm Sci; 2019 Jun; 134():116-137. PubMed ID: 30981885
[TBL] [Abstract][Full Text] [Related]
20. Traditional Chinese medicine for pulmonary fibrosis therapy: Progress and future prospects.
Li LC; Kan LD
J Ethnopharmacol; 2017 Feb; 198():45-63. PubMed ID: 28038955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
